Latest News
Get real-time updates on the latest news and developments in the pharmaceutical world. Stay informed about new drug launches, research findings, regulatory changes, and industry updates. Explore a wide range of topics and stay connected with the rapidly evolving world of pharma.
Roche & Alnylam partner: Hypertension RNAi Therapy – Zilebesiran
Source – Roche Roche has recently unveiled an exciting collaboration with Alnylam to jointly develop and commercialize zilebesiran, a promising ...
Biktarvy Continues to Show Safety and Efficacy Across Diverse Populations Impacted by the Global HIV Epidemic: Updated Findings from IAS 2023
Source – Gilead Gilead Sciences, has released the results of several studies further solidifying Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir ...
Sandoz’s Biosimilar Natalizumab Receives Positive CHMP Opinion for Multiple Sclerosis Treatment
Source – Novartis On July 24, 2023 Sandoz announced a significant milestone. The Committee for Medicinal Products for Human Use ...
EU CHMP Grants Favorable Opinion to Merck’s Keytruda Combination for HER2-Positive Advanced Gastric Cancer
Source – Merck A new hope for patients with advanced gastric or GEJ cancer that is positive for both HER2 ...
CHMP Backs Approval of Pembrolizumab Combination Therapy for HER2+ Gastric Cancer in the EU
Source – Merck A new combination therapy for patients with advanced gastric or GEJ cancer that is positive for both ...
CHMP Greenlights Elacestrant for Advanced Breast Cancer Treatment in the EU
Source – Menarini Group A new treatment option for postmenopausal women with advanced or metastatic breast cancer has moved a ...
In a $466 million agreement, Sosei acquires the Japan and Korea subsidiaries of Idorsia
Source – Sosei Heptares Japan’s Sosei Group has successfully transformed into a commercial-stage pharmaceutical company by acquiring the rights to ...
Astellas and Eko Partner for Heart Failure Digital Therapeutics with Eko CORE 500ā¢ Stethoscope
Source – Astellas Pharma Astellas has obtained the licensing rights to a smart stethoscope device developed by Eko Health, with ...
Pfizer’s North Carolina Facility Hit by Tornado, Raising Concerns About US Medication Supply
A massive sterile injectables facility, considered one of the world’s largest, has fallen victim to a devastating natural disaster. On ...
Mirati’s KRAS Inhibitor Krazati Faces Rejection in Europe
Source – Mirati Therapeutics Mirati Therapeutics has faced a setback in its quest to market its lead KRAS inhibitor Krazati, ...
Enhanced Merger Standards by FTC and DOJ Signal Heightened Scrutiny of M&A Transactions
As the Federal Trade Commission (FTC) closely examines two significant biopharma mergers, both the FTC and the Department of Justice ...
Darzalex Continues Rising Trend – J&J Boosts Projected Yearly Revenues by $1 Billion
In 2017, Genmab CEO Jan van de Winkel envisioned that the multiple myeloma drug Darzalex, marketed by Johnson & Johnson, ...
Medicare prescription coverage for obesity is supported by legislation by Novo Nordisk, Eli Lilly, and Boehringer Ingelheim
Despite the considerable excitement surrounding the potential of new and potent obesity medicines, these drugs remain inaccessible to many Americans ...
Saliva biomarker sought by UK research for speedy stroke detection
In the UK, researchers are working on a rapid and saliva-based test that could help identify stroke patients who require ...
Gilead’s $8 Million Grant Funding for US Viral Hepatitis Relink Program
Source – Gilead FGilead Sciences, on July 20, has introduced the Gilead Relink program, a new grant initiative in the ...
Federal Database Proposal Aims to Track Supply Chain Vulnerabilities
Sen. Gary Peters, D-Michigan, has proposed another bipartisan bill to address the vulnerabilities in the US pharmaceutical supply chain, after ...
FDA Grants Approval to Emergent’s Anthrax Vaccine Cyfendus After 4 Years of Supplying the Shot
Source – Emergent BioSolutons Emergent BioSolutions has been delivering its AV7909 anthrax vaccine to the Department of Health and Human ...
Discontinuation of LOTIS-9 Trial: Zynlonta in Unfit DLBCL Patients
Source – ADC Therapeutics On July 20, 2023, ADC Therapeutics announced its decision to discontinue the Phase II LOTIS-9 clinical ...
KEYNOTE-A18 Trial: Primary Endpoint – Progression-Free Survival in High-Risk Cervical Cancer
Source – Merck Merck has announced a groundbreaking development in its Phase III KEYNOTE-A18 trial, also referred to as ENGOT-cx11/GOG-3047. ...
A new HTA organization promises to “cut the hype” in digital health
The Peterson Centre on Healthcare, a US non-profit, has initiated the creation of the Peterson Health Technology Institute (PHTI) with ...
Pieris Takes Drastic Measures Following AstraZeneca Partnership Loss for Elarekibep
Source – Pieris Pharmaceuticals AstraZeneca has ended its collaboration with Pieris Pharmaceuticals on the respiratory drug candidate elarekibep, leading Pieris ...
Some individuals’ cognitive deterioration may be slowed by hearing aids
Amid the focus on expensive therapies targeting amyloid for Alzheimer’s disease, a new clinical study highlights an alternative approach to ...
J&J has been forced to compensate a mesothelioma sufferer $18.8 million in a talc dispute, but has vowed to appeal
During a period of nationwide freezing on Johnson & Johnson’s talc litigation, one case managed to proceed and resulted in ...
Saxenda is now in low supply as Novo Nordisk issues a supply warning till 2023
Due to a shortage of Novo Nordisk’s popular obesity medicine Wegovy, there has been a surge in demand for their ...
GSK-Financed Study Shows Global Decline in Adult Immunization Rates
Despite the widespread attention given to COVID-19 vaccines in recent times, there has been a significant decline in the uptake ...
Eisai Unveils Lecanemab’s Alzheimer’s Breakthrough at AAIC 2023
Source – Eisai July 20, 2023 Biogen revealed the results of a comprehensive analysis of the Phase III Clarity AD ...
Roche’s Vabysmo Shows Promising Vision Loss Improvement at ASRS
Source – Roche On July 20, Roche announced that they will be presenting data from their ophthalmology portfolio in 25 ...
Gilead’s IAS 2023: Advancing Health Equity and HIV Pipeline Progress
Source – Gilead On July 20, a leading force in HIV innovation, announced its significant participation in the 12th International ...
Sandoz Plans Biosimilar Technical Development Centre in Slovenia for Future Pipeline Expansion
Source – Novartis July 20, 2023, Sandoz, a renowned global leader in generic and biosimilar medicines, has disclosed a substantial ...
Pfizer Unveils Promising GBS Maternal Vaccine in New England Journal of Medicine
Source – Pfizer On July 19, Pfizer released promising data from a Phase II study of their GBS6 vaccine candidate, ...
